Horizon Therapeutics (HZNP) PT Raised to $100 at BofA Securities After Including Viela
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $100.00 (from $99.00) to incorporate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
